ST中珠：12月9日召开董事会会议

Group 1 - The core viewpoint of the article highlights that ST Zhongzhu (SH 600568) held its 14th meeting of the 10th Board of Directors on December 9, 2025, via teleconference to discuss the proposal for the 2025 fourth extraordinary shareholders' meeting [1] - For the first half of 2025, ST Zhongzhu's revenue composition is as follows: hospital income accounts for 56.92%, real estate projects 25.88%, pharmaceutical industry 8.93%, medical devices 4.15%, and center cooperation 3.59% [1] - As of the report date, ST Zhongzhu's market capitalization is 5.3 billion yuan [1] Group 2 - The article also mentions a significant issue in the pharmaceutical industry regarding the abuse of pregabalin, marking the first reported case of addiction in China, highlighting vulnerabilities in online platforms that allow drug purchases without medical records [1]